Cell-Free DNA BCT by Streck Inc.

Cell-Free DNA BCT is a direct draw blood collection tube which stabilizes nucleated blood cells. The unique preservative limits the release of genomic DNA, allowing isolation of high-quality cell-free DNA. Cell-Free DNA BCT has also been demonstrated to minimize the degradation of circulating tumor cells (CTCs). By limiting cell lysis, the specialized chemistry provides sample integrity during storage, shipping and handling of blood samples. Cell-free DNA and gDNA are stable for up to 14 days at 6 °C to 37 °C. CTCs are stable for up to 7 days at 15 °C to 30 °C.

Cell-Free DNA BCT eliminates the need for immediate plasma preparation and CTC processing, allowing for convenient transportation from the collection site to a centralized testing location or reference lab for analysis.

Features

• 14-day cfDNA/gDNA sample stability at 6 °C to 37 °C
• 7-day CTC sample stability at 15 °C to 30 °C
• Reagent stabilizes cfDNA without impacting downstream assays
• Available in 10 mL draw

Benefits

• Eliminates the need for immediate plasma preparation and CTC processing
• High-quality cfDNA can be used for a wide range of downstream applications
• Allows for room temperature storage and shipping of critical samples
• Over 100 peer-reviewed publications feature Streck Cell-Free DNA BCT in their studies

Cell-Free DNA BCT is cleared by the US Food and Drug Administration (FDA)*. CE marked or Research Use Only (RUO) versions are also available, depending on location. For more information on availability in your region, please contact Streck or visit Streck.com.

*Performance characteristics of this device have only been established on the Guardant360 CDx assay.